Moneycontrol PRO

business

Bull's Eye: Buy SPARC, BEL, NCC, Sun Pharma, LIC Housing

Dharmesh Kant of India Nivesh Securities is of the view that one may buy NCC with a target of Rs 90.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark